BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22467557)

  • 1. Applying Motivational Interviewing to the initiation of long-acting injectable atypical antipsychotics.
    Kisely S; Ligate L; Roy MA; Lavery T
    Australas Psychiatry; 2012 Apr; 20(2):138-42. PubMed ID: 22467557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivational interviewing: addressing ambivalence to improve medication adherence in patients with bipolar disorder.
    Laakso LJ
    Issues Ment Health Nurs; 2012 Jan; 33(1):8-14. PubMed ID: 22224961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
    Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
    J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical guideline recommendations for antipsychotic long-acting injections.
    Kane JM; Garcia-Ribera C
    Br J Psychiatry Suppl; 2009 Nov; 52():S63-7. PubMed ID: 19880920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The application of motivational interviewing in nursing practice].
    Wu CC; Lin CC
    Hu Li Za Zhi; 2009 Apr; 56(2):89-93. PubMed ID: 19319809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of patients who would benefit from LAI antipsychotic treatment: how to assess adherence.
    Correll CU
    J Clin Psychiatry; 2014 Nov; 75(11):e29. PubMed ID: 25470105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief motivational interviewing as a clinical strategy to promote asthma medication adherence.
    Borrelli B; Riekert KA; Weinstein A; Rathier L
    J Allergy Clin Immunol; 2007 Nov; 120(5):1023-30. PubMed ID: 17904625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge about antipsychotic long-acting injections: bridging that gap.
    Burns T
    Br J Psychiatry Suppl; 2009 Nov; 52():S5-6. PubMed ID: 19880917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using distance education to promote the transfer of motivational interviewing skills among behavioral health professionals.
    Shafer MS; Rhode R; Chong J
    J Subst Abuse Treat; 2004 Mar; 26(2):141-8. PubMed ID: 15050091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "medication interest model": an integrative clinical interviewing approach for improving medication adherence--part 1: clinical applications.
    Shea SC
    Prof Case Manag; 2008; 13(6):305-15; quiz 316-7. PubMed ID: 19008755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking the role of long-acting atypical antipsychotics in the community setting.
    Altamura AC; Aguglia E; Bassi M; Bogetto F; Cappellari L; De Giorgi S; Fagiolini A; Ferrannini L; Girardi P
    Int Clin Psychopharmacol; 2012 Nov; 27(6):336-49. PubMed ID: 22859065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic long-acting injections in clinical practice: medication management and patient choice.
    Gray R; Spilling R; Burgess D; Newey T
    Br J Psychiatry Suppl; 2009 Nov; 52():S51-6. PubMed ID: 19880918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivational interviewing: building rapport with clients to encourage desirable behavioral and lifestyle changes.
    Tahan HA; Sminkey PV
    Prof Case Manag; 2012; 17(4):164-72; quiz 173-4. PubMed ID: 22660338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudinal barriers to prescribing LAI antipsychotics in the outpatient setting: communicating with patients, families, and caregivers.
    Kane JM
    J Clin Psychiatry; 2014 Dec; 75(12):e33. PubMed ID: 25551245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical perspective on antipsychotic long-acting injections.
    Johnson DA
    Br J Psychiatry Suppl; 2009 Nov; 52():S7-12. PubMed ID: 19880921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teaching students behavior change skills: description and assessment of a new Motivational interviewing curriculum.
    White LL; Gazewood JD; Mounsey AL
    Med Teach; 2007 May; 29(4):e67-71. PubMed ID: 17786734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motivational interviewing techniques - facilitating behaviour change in the general practice setting.
    Hall K; Gibbie T; Lubman DI
    Aust Fam Physician; 2012 Sep; 41(9):660-7. PubMed ID: 22962639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Keith S
    Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.